Findings based on analysis of reviews vs other methods, including nicotine replacement and non-nicotine e-cigarettes.

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

203 kava exposures reported in 2025; reports involving combined use of kava and kratom reached 30 percent of all kava reports in 2025 ...

HealthDay News — Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a study published online March ...

HealthDay News — The US is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Officials say tariffs could reach as high as 100% on certain ...

Budoprutug is an investigational, humanized monoclonal antibody designed to selectively target and bind to CD19 antigen on B cells.

HealthDay News — Transcutaneous electrical nerve stimulation (TENS) plus outpatient physical therapy (PT) reduces movement-based pain in patients with fibromyalgia, according to a study published ...

KT may reduce pain intensity in immediate, short term and improve function/disability in immediate term, but evidence is ...

The proposed 2027 budget would give HHS about $111.1 billion, down roughly $15.8 billion from its current funding. The plan comes from President Donald Trump, but Congress will decide what actually ...

HealthDay News — Treatment with upadacitinib is safe and effective for adults and adolescents with nonsegmental vitiligo (NSV), according to a study presented at the annual meeting of the American ...

The FDA is expected to decide on treatments for ADHD, Alzheimer disease, breast cancer, diabetes, and myasthenia gravis.

A unanimous United States Supreme Court decision has now removed a significant procedural hurdle for medical malpractice plaintiffs in 28 states. In this case, the Court was asked to determine whether ...